Merck is a leading company for innovative and top-quality high-tech products in the pharmaceutical and chemical sectors.
Around 38,000 employees work in 66 countries to improve the quality of life for patients, to further the success of our customers, and to help meet global challenges. In 2013, we generated total revenues of € 11.1 billion with our four divisions: Merck Serono, Consumer Health, Performance Materials and Merck Millipore.
Merck is changing. We are on track with our transformation and growth program known as “Fit for 2018”. In 2007, we started with the realignment of our portfolio, refilled key management positions, fundamentally refocused our organization, and then implemented an efficiency program across all divisions and regions. The success achieved to date shows that our strategy is working. We have considerably improved not only our sales and earnings, but also our profitability.
At the same time, we remain true to our roots and tradition. Merck is the world’s oldest pharmaceutical and chemical company. Since 1668 our name has stood for innovation, business success and responsible entrepreneurship. The founding family remains the majority owner of the company to this day.
We are Merck, the original, and hold the global rights to the Merck name and brand. The only exceptions are Canada and the United States, where we are known as EMD.
| XLS |
|
Merck Group | Key figures |
|||
|
|
|
|
|
|
|
|
|
|
|
€ million |
2013 |
2012 |
Change in % |
|
Total revenues |
11,095.1 |
11,172.9 |
–0.7 |
|
Sales |
10,700.1 |
10,740.8 |
–0.4 |
|
Operating result (EBIT) |
1,610.8 |
963.6 |
67.2 |
|
Margin (% of sales) |
15.1 |
9.0 |
|
|
EBITDA |
3,069.2 |
2,360.2 |
30.0 |
|
Margin (% of sales) |
28.7 |
22.0 |
|
|
EBITDA pre one-time items |
3,253.3 |
2,964.9 |
9.7 |
|
Margin (% of sales) |
30.4 |
27.6 |
|
|
EPS (in €) |
5.53 |
2.61 |
111.9 |
|
EPS pre one-time items (in €) |
8.78 |
7.61 |
15.4 |
|
Business free cash flow |
2,960.0 |
2,969.3 |
–0.3 |
Group sales
EBITDA pre one-time items
